Potent Antiviral HIV-1 Protease Inhibitor GRL-02031 Adapts to the Structures of Drug Resistant Mutants with Its P1;#8242;-Pyrrolidinone Ring
- GSU
GRL-02031 (1) is an HIV-1 protease (PR) inhibitor containing a novel P1' (R)-aminomethyl-2-pyrrolidinone group. Crystal structures at resolutions of 1.25-1.55 {angstrom} were analyzed for complexes of 1 with the PR containing major drug resistant mutations, PR{sub I47V}, PR{sub L76V}, PR{sub V82A}, and PR{sub N88D}. Mutations of I47V and V82A alter residues in the inhibitor-binding site, while L76V and N88D are distal mutations having no direct contact with the inhibitor. Substitution of a smaller amino acid in PR{sub I47V} and PR{sub L76V} and the altered charge of PR{sub N88D} are associated with significant local structural changes compared to the wild-type PR{sub WT}, while substitution of alanine in PR{sub V82A} increases the size of the S1' subsite. The P1' pyrrolidinone group of 1 accommodates to these local changes by assuming two different conformations. Overall, the conformation and interactions of 1 with PR mutants resemble those of PR{sub WT} with similar inhibition constants in good agreement with the antiviral potency on multidrug resistant HIV-1.
- Research Organization:
- Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
- Sponsoring Organization:
- OTHERUNIVERSITYNIH
- OSTI ID:
- 1047901
- Journal Information:
- J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (7) ; 04, 2012 Vol. 55; ISSN JMCMAR; ISSN 0022-2623
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies
Molecular Basis for Substrate Recognition and Drug Resistance from 1.1 to 1.6 Angstrom Resolution Crystal Structures of HIV-1 Protease Mutants with Substrate Analogs
Design, Synthesis, Evaluation, and Crystallographic-Based Structural Studies of HIV-1 Protease Inhibitors with Reduced Response to the V82A Mutation
Journal Article
·
Wed Sep 02 00:00:00 EDT 2009
· J. Med. Chem.
·
OSTI ID:1005843
Molecular Basis for Substrate Recognition and Drug Resistance from 1.1 to 1.6 Angstrom Resolution Crystal Structures of HIV-1 Protease Mutants with Substrate Analogs
Journal Article
·
Fri Dec 31 23:00:00 EST 2004
· FEBS J.
·
OSTI ID:913894
Design, Synthesis, Evaluation, and Crystallographic-Based Structural Studies of HIV-1 Protease Inhibitors with Reduced Response to the V82A Mutation
Journal Article
·
Mon Dec 31 23:00:00 EST 2007
· Journal of Medicinal Chemistry
·
OSTI ID:959536